Test Code Billings Clinic: 8749 Mayo: FLEC Flecainide, Serum
Reporting Name
Flecainide, SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Optimizing flecainide dosage
Assessing flecainide toxicity
Monitoring compliance
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Red top (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 1.5 mL
Collection Instructions:
1. Draw blood immediately before next scheduled dose.
2. Centrifuge and aliquot serum into a plastic vial within 2 hours of collection.
Specimen Type
Serum RedThis test must be drawn in a PLAIN RED TOP - NO GEL
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum Red | Refrigerated (preferred) | 28 days | |
Ambient | 28 days | ||
Frozen | 28 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Reference Values
Trough Value
0.2-1.0 mcg/mL: Therapeutic concentration
>1.0 mcg/mL: Toxic concentration
Interpretation
Flecainide is most effective in premature ventricular contractions suppression at serum concentrations in the range of 0.2 to 1.0 mcg/mL.
Serum concentrations above 1.0 mcg/mL are associated with a high rate of cardiac adverse experiences such as conduction defects or bradycardia.
Day(s) Performed
Monday through Friday
Report Available
2 to 5 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80181
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
FLEC | Flecainide, S | 3638-4 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
9243 | Flecainide, S | 3638-4 |
Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.